CG인바이츠

083790KOSDAQ자연과학 및 공학 연구개발업

50.3 / 100

Reference Date: 2026-07-24

Financial Score20.0 / 40

News Sentiment20.3 / 25

Momentum3.0 / 20

Disclosure7.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Plunged 22.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

CGinBites operates in pharmaceutical R&D, AI healthcare solutions, and thermal patch manufacturing, with key projects including the approved drug 'Acell克斯' and ongoing clinical trials for cancer treatments. The company leads medical innovation through precision medicine platforms based on genomic analysis and AI-driven digital healthcare solutions. It also contributes to ecosystem expansion via venture investments and startup support.

Number of Employees

92people

Average Salary

60.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

0.50Industry Average 2.527.0Point

Half of industry avg (excellent)

ROE

-10.45Industry Average -32.093.5Point

Well below industry avg

Debt Ratio

13.45Industry Average 7.310.5Point

1.8x industry avg (risky)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲163.2% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲6.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -26.3% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 4Neutral 0Negative 1Average Sentiment Score 81

Positive
에즈큐리스, 아스트라제네카와 신약 발굴 공동 연구 계약
에즈큐리스와 아스트라제네카의 협력으로 CG인바이츠 관련 신약 개발 가능성이 높아져 긍정적 영향 기대.
Negative
CG인바이츠, 55억원 약정금 소송 항소심 제기
CG인바이츠가 원고로부터 55억원 규모의 추가 지급을 요구하는 항소를 제기받아 재무 부담이 증가했다.
Positive
CG인바이츠, 디지털헬스케어 얼라이언스에 KMI 합류…해외 진출 속도
CG인바이츠의 해외 디지털헬스케어 시장 진출 가속화로 긍정적인 전망.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 774Won52-week high 1,88752-week low 774

1-month return0.0Point

1m -22.68% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

10 totalPositive 0Neutral 9Negative 1

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-23
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-23
Negative소송등의제기ㆍ신청(일정금액이상의청구) (약정금)2026-07-13
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-06
Neutral주식등의대량보유상황보고서(일반)2026-07-01